On Tuesday, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) opened higher 0.81% from the last session, before settling in for the closing price of $28.33. Price fluctuations for TEVA have ranged from $12.47 to $28.74 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.65%. Company’s average yearly earnings per share was noted 6.46% at the time writing. With a float of $1.14 billion, this company’s outstanding shares have now reached $1.15 billion.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Teva- Pharmaceutical Industries Ltd. ADR is 0.16%, while institutional ownership is 58.27%. The most recent insider transaction that took place on Dec 09 ’25, was worth 6,230,750. Before that another transaction happened on Dec 09 ’25, when Company’s Officer proposed sale 115,468 for $28.68, making the entire transaction worth $3,311,131.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.71 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.7) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.72% during the next five years compared to -9.65% drop over the previous five years of trading.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Trading Performance Indicators
Check out the current performance indicators for Teva- Pharmaceutical Industries Ltd. ADR (TEVA). In the past quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.94. Likewise, its price to free cash flow for the trailing twelve months is 130.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit 0.66 in the next quarter and is forecasted to reach 2.77 in one year’s time.
Technical Analysis of Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
The latest stats from [Teva- Pharmaceutical Industries Ltd. ADR, TEVA] show that its last 5-days average volume of 10.44 million was inferior to 11.8 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 89.50%.
During the past 100 days, Teva- Pharmaceutical Industries Ltd. ADR’s (TEVA) raw stochastic average was set at 96.17%, which indicates a significant increase from 89.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.64 in the past 14 days, which was higher than the 0.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.71, while its 200-day Moving Average is $18.20. Now, the first resistance to watch is $28.93. This is followed by the second major resistance level at $29.31. The third major resistance level sits at $29.52. If the price goes on to break the first support level at $28.35, it is likely to go to the next support level at $28.14. Assuming the price breaks the second support level, the third support level stands at $27.76.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Key Stats
There are currently 1,146,960K shares outstanding in the company with a market cap of 32.75 billion. Presently, the company’s annual sales total 16,544 M according to its annual income of -1,639 M. Last quarter, the company’s sales amounted to 4,480 M and its income totaled 433,000 K.
